TATUM BOHLS: Open Payments
NPI 1487050175 · PFLUGERVILLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,013 in 29 payments from 16 companies in 2025. Trend: 2023 $533 · 2024 $901 · 2025 $1,013
Food & beverage: $1,013
| Company | Payments | Amount |
|---|---|---|
| Ferring Pharmaceuticals Inc. | 6 | $163 |
| 180 Medical, Inc. | 4 | $162 |
| Boston Scientific Corporation | 3 | $162 |
| Astellas Pharma US Inc | 1 | $98 |
| Calyxo, Inc. | 1 | $90 |
| Janssen Biotech, Inc. | 1 | $69 |
| TOLMAR, INC. | 2 | $42 |
| IMMUNITYBIO, INC. | 2 | $41 |
| UROGEN PHARMA, INC. | 2 | $34 |
| ABBVIE INC. | 1 | $27 |
Products named: ADSTILADRIN, AMS 700, Xtandi, CVAC ASPIRATION SYSTEM, RYBREVANT, JATENZO, ANKTIVA, JELMYTO.
Industry payments across TX — which companies pay providers there.
